Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析

◆英語タイトル:Arbutus Biopharma Corp (ABUS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4335FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:55
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥43,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Arbutus Biopharma Corp (ABUS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Arbutus Biopharma Corp (Arbutus Biopharma), formerly Tekmira Pharmaceuticals Corp, focuses on the discovery, development, and commercialization of proprietary drugs and drug delivery systems indicated for the treatment of chronic hepatitis B infection (HBV). Its pipeline includes capsid assembly inhibitors: AB-729, AB-836 and a HBV RNA destabilizer. The company develops product candidates based on its lipid nanoparticle (LNP) delivery technology. Arbutus Biopharma works in partnership and collaboration with Genevant Sciences Inc, Alnylam Pharmaceuticals Inc, Acrotech Biopharma LLC and Gritstone Oncology. It operates in the US and Canada. Arbutus Biopharma is headquartered in Warminster, Pennsylvania, the US.

Arbutus Biopharma Corp Key Recent Developments

Apr 28,2021: Arbutus to Report First Quarter 2021 Financial Results and Provide Corporate Update
Mar 04,2021: Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Feb 22,2021: Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
Jan 25,2021: Arbutus announces 2021 corporate objectives and provides financial update
Nov 05,2020: Arbutus reports third quarter 2020 financial results and provides corporate update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Arbutus Biopharma Corp – Key Facts
Arbutus Biopharma Corp – Key Employees
Arbutus Biopharma Corp – Key Employee Biographies
Arbutus Biopharma Corp – Major Products and Services
Arbutus Biopharma Corp – History
Arbutus Biopharma Corp – Company Statement
Arbutus Biopharma Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Arbutus Biopharma Corp – Business Description
Business Segment: Non-Cash Royalty Revenue
Performance
Business Segment: Revenue from Collaborations and Licenses
Performance
R&D Overview
Arbutus Biopharma Corp – Corporate Strategy
Arbutus Biopharma Corp – SWOT Analysis
SWOT Analysis – Overview
Arbutus Biopharma Corp – Strengths
Arbutus Biopharma Corp – Weaknesses
Arbutus Biopharma Corp – Opportunities
Arbutus Biopharma Corp – Threats
Arbutus Biopharma Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Arbutus Biopharma Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 28, 2021: Arbutus to Report First Quarter 2021 Financial Results and Provide Corporate Update
Mar 04, 2021: Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update
Feb 22, 2021: Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update
Jan 25, 2021: Arbutus announces 2021 corporate objectives and provides financial update
Nov 05, 2020: Arbutus reports third quarter 2020 financial results and provides corporate update
Aug 07, 2020: Arbutus reports second quarter 2020 financial results and provides corporate update
May 11, 2020: Arbutus reports first quarter 2020 financial results, provides pipeline update and announces new research initiative to identify novel antiviral therapies for the treatment of coronavirus infections
Mar 05, 2020: Arbutus reports fourth quarter and year end 2019 financial results, confirms 2020 corporate objectives and provides pipeline update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Arbutus Biopharma Corp, Key Facts
Arbutus Biopharma Corp, Key Employees
Arbutus Biopharma Corp, Key Employee Biographies
Arbutus Biopharma Corp, Major Products and Services
Arbutus Biopharma Corp, History
Arbutus Biopharma Corp, Joint Venture
Arbutus Biopharma Corp, Key Competitors
Arbutus Biopharma Corp, Ratios based on current share price
Arbutus Biopharma Corp, Annual Ratios
Arbutus Biopharma Corp, Annual Ratios (Cont...1)
Arbutus Biopharma Corp, Interim Ratios
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Arbutus Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Arbutus Biopharma Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Arbutus Biopharma Corp (ABUS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Banesco Banco Universal C.A.:企業の戦略・SWOT・財務情報
    Banesco Banco Universal C.A. - Strategy, SWOT and Corporate Finance Report Summary Banesco Banco Universal C.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Shimadzu Corp (7701)
    Shimadzu Corp (7701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Ferrellgas Partners LP (FGP):企業の財務・戦略的SWOT分析
    Summary Ferrellgas Partners LP (Ferrellgas) is an oil and gas company that supplies propane and related equipment. The company provides transportation, wholesale marketing, and distribution of propane. It also carries out selling refined fuels and feedstocks. Ferrellgas provides propane crop drying, …
  • NanoViricides Inc (NNVC)-製薬・医療分野:企業M&A・提携分析
    Summary NanoViricides Inc (NanoViricides), formerly Edot-com.com Inc is a biopharmaceutical company that provides nanomedicine technology solutions. The company conducts research in the areas of medical science and pharmaceutical technology such as polymeric micelles, multi-specific multi-targeting, …
  • AMC Entertainment Holdings, Inc.:企業の戦略・SWOT・財務分析
    AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Fujifilm SonoSite Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • Philippine Bank Of Communications
    Philippine Bank Of Communications - Strategy, SWOT and Corporate Finance Report Summary Philippine Bank Of Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Edwards Lifesciences Corp (EW):企業の財務・戦略的SWOT分析
    Edwards Lifesciences Corp (EW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Morcher Gmbh:企業の製品パイプライン分析2018
    Summary Morcher Gmbh (Morcher) is a medical device company that develops, manufactures, and distributes implants for cataract surgery. The company’s products include capsular tension rings, eyejet ctr - preloaded capsular tension rings, cionni rings for scleral fixation, capsular segment for scleral …
  • Cosucra Groupe Warcoing SA:戦略・SWOT・企業財務分析
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Public Bank Berhad:戦略・SWOT・企業財務分析
    Public Bank Berhad - Strategy, SWOT and Corporate Finance Report Summary Public Bank Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • International Seaways Inc (INSW)-石油・ガス分野:企業M&A・提携分析
    Summary International Seaways Inc (INSW) owns and operates a fleet of oceangoing vessels involved in the transportation of crude oil and petroleum products. The company holds ownership in LNG (liquefied natural gas) carriers and FSO (floating storage and offloading) service vessels. It charters the …
  • Empresa Nacional del Petroleo:石油・ガス:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Korea Aerospace Industries Ltd.:企業の戦略・SWOT・財務情報
    Korea Aerospace Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Korea Aerospace Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Wilbur-Ellis Holdings Inc:企業の戦略的SWOT分析
    Wilbur-Ellis Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Dai-ichi Life Holdings, Inc.:企業の戦略・SWOT・財務情報
    Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dai-ichi Life Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Corium International Inc (CORI):企業の製品パイプライン分析2018
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Protalex Inc (PRTX):企業の財務・戦略的SWOT分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • LRAD Corporation:企業の戦略・SWOT・財務情報
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆